Targeted nanoparticles for multimodal imaging of the receptor for advanced glycation end-products

The receptor for advanced glycation end-products (RAGE) is implicated in multiple disease states such as cancer, diabetes and neurodegenerative disorders, and RAGE inhibitors are being explored as potential new therapies in such cases. Despite the known role RAGE plays in these conditions, there rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Drake, Lindsey R., Scott, Peter J. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299691/
https://www.ncbi.nlm.nih.gov/pubmed/30613302
http://dx.doi.org/10.7150/thno.31515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299691/
https://www.ncbi.nlm.nih.gov/pubmed/30613302
http://dx.doi.org/10.7150/thno.31515

Ejemplares similares